Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).

被引：0
|
作者：
Saven, A
Burian, C
Kosty, M
Mason, J
Douer, D
机构：
[1] Ida M & Cecil H Green Canc Ctr, Div Hematol Oncol, Scripps Clin, La Jolla, CA USA
[2] Univ So Calif, Div Hematol, Norris Canc Ctr, Los Angeles, CA USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4459
引用
收藏
页码：279B / 279B
页数：1
相关论文
共 50 条
  • [31] Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia
    Kattan, MW
    Inoue, Y
    Giles, FJ
    Talpaz, M
    Ozer, H
    Guilhot, F
    Zuffa, E
    Huber, SL
    Beck, JR
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (07) : 541 - +
  • [32] Association of HLA phenotype and response to interferon-alpha in patients with chronic myelogenous leukemia
    Cortes, J
    Fayad, L
    Kantarjian, H
    O'Brien, S
    Lee, MS
    Talpaz, M
    [J]. LEUKEMIA, 1998, 12 (04) : 455 - 462
  • [33] Late cytogenetic and molecular response to interferon-α (IFN-α) in chronic myelogenous leukemia (CML).
    Nosari, A
    Perego, R
    Pungolino, E
    Cornacchini, G
    Gargantini, L
    Morra, E
    [J]. BLOOD, 1998, 92 (10) : 627A - 627A
  • [34] Association of hla phenotype and response to interferon alfa (IFN) in patients with chronic myelogenous leukemia (CML).
    Cortes, J
    Kantarjian, H
    Talpaz, M
    [J]. BLOOD, 1995, 86 (10) : 1739 - 1739
  • [35] Hudroxyurea (HOU) treatment of chronic myelogenous leukemia (CML) induced MDR-1 gene expression in haemopoietic cells whereas interferon-alpha (IFN-alpha) does not.
    Stuif, I
    Frolova, O
    Bykova, T
    Afanasiev, B
    Zaritskey, A
    [J]. EXPERIMENTAL HEMATOLOGY, 1996, 24 (09) : 297 - 297
  • [36] Quantification of residual disease in chronic myelogenous leukemia (CML) patients on interferon-alpha therapy by competitive polymerase chain reaction.
    Hochhaus, A
    Reiter, A
    Skladny, H
    Lin, F
    Mason, PJ
    vanRhee, F
    Shepherd, PCA
    Allan, NC
    Hehlmann, R
    Goldman, JM
    Cross, NCP
    [J]. BLOOD, 1995, 86 (10) : 1064 - 1064
  • [37] INTERFERON-ALPHA THERAPY DURING PREGNANCY IN CHRONIC MYELOGENOUS LEUKEMIA AND HAIRY-CELL LEUKEMIA
    BAER, MR
    OZER, H
    FOON, KA
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (02) : 167 - 169
  • [38] INTERFERON-ALPHA THERAPY IN CHRONIC MYELOGENOUS LEUKEMIA - QUESTIONS RELATED TO THE GERMAN RANDOMIZED TRIAL
    KANTARJIAN, HM
    TALPAZ, M
    [J]. BLOOD, 1995, 85 (10) : 2998 - 2999
  • [39] Cost-effectiveness of interferon-alpha as maintenance therapy in chronic myelogenous leukemia - Response
    Kattan, MW
    Beck, JR
    [J]. ANNALS OF INTERNAL MEDICINE, 1997, 126 (08) : 664 - 665
  • [40] HEMOLYTIC-UREMIC SYNDROME IN A PATIENT WITH CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH INTERFERON-ALPHA
    SCHLAIFER, D
    DUMAZER, P
    SPENATTO, N
    MIGNONCONTE, M
    BROUSSET, P
    LUMBROSO, C
    COOPER, M
    MULLER, C
    HUGUET, F
    ATTAL, M
    LAURENT, G
    PRIS, J
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1994, 47 (03) : 254 - 255
12345